IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1135-1141

  Dolores Boyano, M ^a   De Galdeano, Alicia García ^a   Smith Zubiaga, Isabel ^a   Cañavate, M Luz ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

B16F10 melanoma; In vitro IL 2 treatment; Metastatic ability

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOMETRY; DRUG EFFECT; GENE EXPRESSION; LIVER METASTASIS; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RNA, MESSENGER;

EID: 1842299800     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Taniguchi T, Minami Y: The IL-2/1L-2 receptor system: a current overview. Cell 73: 5-8, 1993.
2. Oppenheim MH, Lotze MT: Interleukin-2: solid-tumor therapy. Oncology 51: 154-169, 1994.
3. Nagarkatti M, Hassuneh M, Seth A, Manickasundari K, Nagarkatti PS: Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells. Proc Natl Acad Sci USA 91: 7638-7642, 1994.
4. Paciotti GF, Tamarkin L: Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo. Anticancer Res 8: 1233-1240, 1988.
5. Carloni G, Paterson H, Mareel M, Augery-Bourget Y, Sahraoui J, Rubinstein E, Suarez H, Azzarone B: N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype. Oncogene 4: 873-880, 1989.
6. Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK: Interleukin-2 and Interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest 90: 1944-1951, 1992.
7. Plaisance S, Rubinstein E, Alileche A, Han DS, Sahraoui Y, Mingari MC, Bellomo R, Rimoldi D, Colombo MP, Jasmin C, Carrel S, Azzarone B: Human melanoma cells express a functional interleukin2 receptor. Int J Cancer 55: 164-170, 1993.
8. Garcia de Galdeano A, Boyano MD, Smith-Zubiaga I, Cañavate ML: B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2 receptor. Tumor Biol 17: 155-167, 1996.
9. Barberá-Guillem E, Cañavate ML, López de Tejada I, Vidal-Vanaclocha F: Influence of host defenses on the hepatic colonization of B16F10 melanoma cells. Clin Expl Metastasis 6: 153-169, 1988.
10. Muegge K, Williams TM, Kant J, Karin M, Chiu R, Schmidt A, Siebenlist U, Young HA, Durum SK: Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 246: 249251, 1989.
11. Holsti MA, Raulet DH: IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. J Immunol 143: 2514-2519, 1989.
12. Randak C, Brabletz T, Hergenröther M, Sobottu I, Serfling E: Cyclosporin A supresses the expression of the inierleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J 9: 2529-2536, 1990.
13. Tao T, Matter A, Vogel K, Burger MM: Liver-colonizing melanoma cells selected from B-16 melanoma. Int J Cancer 23: 854-857, 1979.
14. Rusciano D, Lorenzoni P, Burger MM: Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells. Invasion Met 13: 212-224, 1993.
15. Kopper L, Van Hanh T, Lapis K: Experimental model for liver metastasis formation using Lewis lung tumor: J Cancer Res Clin Oncol 103: 31-38, 1982.
16. Hanna N: The role of natural killer cells in the control of tumor growth and metastasis. Biochem Biophys Acta 780: 213-226, 1985.
17. Gorelik E, Gunji Y, Herberman RB: H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity. J Immunol 140: 2096-2102, 1988.
18. Reiter Z, Rappaport B: Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Crit Rev Immunol 13: 1-34, 1993.
19. Lahat N, Aghai E, Kotler A, Kinarty A, Sobel E, Gruener N, Froom P: Discordant effect of Interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia. Blood 71: 1141-1143, 1988.
20. Reiter Z, Ozes ON, Blatt LM, Taylor MW; Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-a and intcrleukin-2. J Immunother 11: 40-49, 1992.
21. Taniguchi K, Kärre K, Klein G: Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell. Int J Cancer 36: 503-510, 1985.
22. - cells in metastatic processes. J Immunol 136: 4729-4734, 1986.
23. Gorelik E, Kim M. Duty L, Henion T, Galili U: Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: inmunological and nonimunological mechanisms. Clin Hxpl Metastasis 11: 439-452, 1993.
24. Eisenbach L, Kushtai G, Plaksin D, Feldman M: MHC genes and oncogenes controlling the metastatic phenotype of tumor cells. Cancer Rev 5: 1-18, 1986.
25. van Vreeswijk H, Ruiter DJ, Brocker EB, Welvaart K, Ferrone S: Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. J Invest Dermatol 90: 755-760, 1988.
26. Boyano ML, Smith-Zubiaga I, Alvarez A, Garcia de Galdeano A, Barbera-Guillem E, Canavate ML: Enhancement of la antigen expression and nonproliferating cells correlates with metastatic capacity. Pathobiology 62: 186-193, 1994.
27. Alileche A, Plaisance S, Han DS, Rubinstein E, Mingari C, Bellomo R, Jasmin C, Azzarone, B: Human melanoma cell line M14 secretes a functional interleukin 2. Oncogene 8: 1791-1796, 1993.
28. Shaw J, Meerovitch K, Bleackley RC, Paetkau V: Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J Immunol 140: 2243-2248, 1988.